Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: Street Walker who wrote (1672)	11/29/1999 8:58:00 PM
From: Mike M	Read Replies (1) \| Respond to of 5582

My 4th quarter earnings estimate....(preliminary) Zicam sales $6.5M* Gum sales $1.1M ----- 7.6M orders currently represent over 5 times last quarter $1.1M but production having difficulty filling....Expect additional manufacturing no earlier than 15 Dec 99...but could be later....assuming worst case! Zicam gross profit margin 60%. 6.5M x .6 = $3.9M gross profit Advertising and interest expenses $1.5M Zicam net profit $2.4 M gum net loss .3 M GUMM net profit 2.1 M 4th quarter EPS.... .27* and....wait til next year!